Omeros Corporation
Omeros Corporation
OMER
Valuace
70
Růst
20
Zdraví
65
Cena
$ 6.61
Dnes
--0.20 (-1.64%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.4B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
55%
ROA
-65%
PE
-6
PS
0
Cena 1R
3-18
⌀ Cena
6.27
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
30-03-2026
Poslední dividenda

Profil

Společnost Omeros Corporation, biofarmaceutická společnost působící v komerčním měřítku, objevuje, vyvíjí a komercializuje léčiva pro malé molekuly a proteiny a indikace pro vzácná onemocnění zaměřená na zánět, nemoci zprostředkované komplementem, rakovinu související s dysfunkcí imunitního systému a návykové a kompulzivní poruchy. Mezi klinické programy společnosti patří Narsoplimab (OMS721/MASP- 2), který dokončil pivotní studie trombotické mikroangiopatie související s transplantací hematopoetických kmenových buněk (HSCT-TMA); to je v klinické studii fáze III zaměřené na imunoglobulin A nefropatii (IgAN) a atypický hemolytický uremický syndrom (aHUS); a klinická studie fáze II zaměřená na léčbu COVID-19. Jeho klinické programy se také skládají z PPAR? (OMS405), který je ve fázi II k léčbě závislosti na opiátech a nikotinu; PDE7 (OMS527), který je ve fázi I klinické studie k léčbě závislosti a kompulzivních poruch a poruch pohybu; a MASP-3 (OMS906), který je ve fázi I klinické studie k léčbě paroxysmální noční hemoglobinurie (PNH) a jiných poruch alternativní dráhy. Preklinické programy společnosti zahrnují inhibitory MASP-2-malých molekul používané k léčbě aHUS, IgAN, HSCT-TMA a stařecké makulární degenerace; dlouhodobě působící protilátky druhé generace zaměřené na MASP-2; a inhibitory MASP-3-malých molekul k léčbě PNH a dalších poruch alternativní dráhy. Předklinické programy zahrnují také GPR174 inhibitory a T-buňky chimerického antigenového receptoru (CAR) a Adoptivní T-buněčné terapie pro různé typy rakoviny; a G protein-vapolované receptorové cíle pro léčbu imunologických, imuno-onkologických, metabolických, CNS, kardiovaskulárních, muskuloskeletálních a dalších poruch. Společnost byla založena v roce 1994 a sídlí v Seattlu ve státě Washington.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
202
Založení
2009-10-08
Adresa
The Omeros Building
CEO
Gregory A. Demopulos

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues0.000.000.000.000.000.0073,813.00111,805.0029,868.0064,826.0041,617.0013,509.00539.001,600.006,022.004,524.002,105.00
Cost of Revenues10,293.000.000.0069,779.000.000.00902.00865.00512.001,078.001,412.001,041.000.000.000.000.000.00
Gross Profit-10,293.000.000.00-69,779.000.000.0072,911.00110,940.0029,356.0063,748.0040,205.0012,468.00539.001,600.006,022.004,524.002,105.00
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues0.000.000.000.000.000.000.000.001,366.000.00
Cost of Revenues0.000.0010,293.000.00301.000.000.00204.00205.00197.00
Gross Profit0.000.00-10,293.000.00-301.000.000.00-204.001,161.00-197.00
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.000.000.00114,870.00112,721.00118,775.00110,817.00109,696.0089,860.0055,599.0050,699.0048,379.0047,946.0036,297.0031,922.0023,718.0023,465.00
Selling General & Admin Expenses0.000.000.0049,660.0050,668.0054,842.0072,695.0064,626.0051,718.0052,044.0043,782.0035,327.0022,601.0015,819.0010,985.008,216.008,746.00
Depreciation & Amortization2,466.000.00950.00920.004,062.001,740.00654.001,553.00962.00551.00300.00209.00326.00302.00320.00435.00472.00
Total Operating Expenses112,503.00122,796.00169,258.0094,751.00163,389.00173,617.00183,512.00174,322.00141,578.00107,643.0094,481.0083,706.0070,547.0052,116.0042,907.0031,934.0032,211.00
Operating Income-122,796.00-122,796.00-169,258.00-164,530.00-163,389.00-173,617.00-110,601.00-63,382.00-112,222.00-43,895.00-54,276.00-71,238.00-70,008.00-50,516.00-36,885.00-27,410.00-30,106.00
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.0028,685.0031,731.00
Selling General & Admin Expenses0.000.000.000.000.000.000.000.0010,875.0016,422.00
Depreciation & Amortization0.001,977.00200.00289.00301.00237.00208.00204.00205.00197.00
Total Operating Expenses29,081.0026,392.0022,061.0034,969.0035,359.0035,407.0059,157.0038,830.0039,560.0048,153.00
Operating Income-29,081.00-26,392.00-32,354.00-34,969.00-35,660.00-35,407.00-59,157.00-39,034.00-39,765.00-48,153.00
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income1,241.000.0011,304.000.004,062.000.000.000.000.000.000.000.000.000.000.000.000.00
Interest Expense8,298.00960.0024,675.0014,502.0022,702.0019,669.0026,751.0022,657.0016,252.0011,030.007,819.003,573.003,470.002,366.001,729.001,884.001,535.00
Other Expense115,430.000.00-13,371.00-10,390.00-18,640.00-17,929.00-39,471.00-21,104.00-11,212.001,444.00-4,650.00-285.00-195.0013,086.00170.00748.002,390.00
IBT-7,366.00-2,796.00-182,629.00-174,920.00-182,029.00-191,546.00-150,072.00-84,486.00-139,686.00-53,481.00-66,745.00-75,096.00-73,673.00-39,796.00-38,444.00-26,662.00-27,716.00
Income Tax Expense-2,012.00-2,012.000.000.00-210,806.00-365,758.00-12,011.0022,420.00-12,929.0011,923.008,464.004,394.002,937.002,940.001,539.001,136.00-855.00
Net Income-3,350.00-3,350.00-156,815.00-117,813.0028,777.00194,235.00-138,061.00-106,906.00-126,757.00-53,481.00-66,745.00-75,096.00-73,673.00-39,796.00-38,444.00-28,546.00-29,251.00
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.000.001,241.000.002,296.002,346.003,247.003,415.000.004,413.00
Interest Expense-8,726.0013,355.0015.003,654.003,177.004,052.009,215.008,231.003,634.007,916.00
Other Expense116,086.00-4,525.006,465.00-2,596.00-881.00-1,706.00-5,968.00-4,816.00478.00-3,503.00
IBT87,005.00-30,917.00-25,889.00-37,565.00-36,541.00-37,113.00-65,125.00-43,850.00-39,287.00-37,750.00
Income Tax Expense-2,012.000.000.000.000.000.000.000.00-30,219.00-197.00
Net Income86,451.00-30,917.00-25,424.00-33,460.00-31,358.00-32,232.00-56,041.00-37,184.00-9,068.00-37,750.00
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-1.88$0.46$3.12$-2.41$-2.16$-2.61$-1.17$-1.65$-2.00$-2.22$-1.39$-1.59$-1.29$-1.37
EPS Diluted$0.00$0.00$0.00$-1.88$0.46$3.12$-2.41$-2.16$-2.61$-1.17$-1.65$-2.00$-2.22$-1.39$-1.59$-1.29$-1.37
Shares Outstanding63,510.2063,510.2058,170.9362,739.2362,737.0962,344.1057,176.7449,523.4448,582.6445,539.3640,446.4137,560.2633,234.2928,560.3624,155.6922,212.3521,420.88
Diluted Shares Outstanding63,510.2063,510.2058,170.9362,739.2362,737.0962,344.1057,176.7449,523.4448,582.6445,539.3640,446.4137,560.2633,234.2928,560.3624,155.6922,212.3521,420.88
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.15$-0.60
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.15$-0.60
Shares Outstanding63,510.2066,263.9958,585.0858,056.3658,170.9357,948.0957,944.0258,800.7262,440.7762,856.72
Diluted Shares Outstanding63,510.2066,263.9958,585.0858,056.3658,170.9357,948.0957,944.0258,800.7262,440.7762,856.72
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents2,120.003,400.007,105.0011,009.00100,808.0010,501.003,084.005,861.003,394.002,224.001,365.00354.001,384.001,520.004,005.003,278.00
Short Term Investments156,792.0086,732.00164,743.00183,909.0056,458.00124,452.0057,704.0054,637.0080,355.0043,107.0026,898.006,532.0012,717.0020,830.0020,565.0038,715.00
Total Cash & ST Investments158,912.0090,132.00171,848.00194,918.00157,266.00134,953.0060,788.0060,498.0083,749.0045,331.0028,263.006,886.0014,101.0022,350.0024,570.0041,993.00
Accounts Receivable37,745.0036,822.006,724.00242,018.0082,474.003,841.0035,185.0022,818.0017,144.0012,037.006,517.00392.00379.001,934.00876.001,479.00
Inventory0.000.000.000.000.00114,549.0048,286.0052,511.00443.001,128.00472.00568.000.000.000.000.00
Other Current Assets6,273.007,166.0039,326.006,300.008,149.0011,136.006,625.006,463.007,036.001,766.001,894.00120.00337.00416.00502.00282.00
Total Current Assets202,930.00134,120.00217,898.00443,236.00247,889.00151,285.00103,745.0089,867.00108,372.0060,262.0037,146.009,157.0014,817.0024,700.0025,948.0043,754.00
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents2,395.001,904.004,261.003,400.001,521.002,120.001,831.007,105.0030,640.006,603.00
Short Term Investments33,690.0026,840.0048,150.0086,732.00121,636.00156,792.00228,503.00164,743.00279,670.00334,680.00
Total Cash & ST Investments36,085.0028,744.0052,411.0090,132.00123,157.00158,912.00230,334.00171,848.00310,310.00341,283.00
Accounts Receivable105,939.0034,497.005,628.0036,822.0035,637.0037,745.0037,161.0037,469.0036,106.0040,274.00
Inventory0.000.000.000.000.000.000.000.000.000.00
Other Current Assets-70,219.006,406.0038,142.007,166.006,127.006,273.0013,463.0039,326.004,922.007,001.00
Total Current Assets71,805.0069,647.0096,181.00134,120.00164,921.00202,930.00280,958.00217,898.00351,338.00388,558.00
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment18,902.0017,639.0020,581.0023,254.0030,007.0028,077.0030,911.003,845.002,121.001,181.00951.00782.00939.001,037.00739.001,622.00
Goodwill0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Long-Term Investments134,482.000.000.000.000.000.000.001,154.000.000.000.000.000.000.000.000.00
Other Long-Term Assets0.00125,320.00139,790.00124,479.00141,372.001,680.002,313.001,070.005,835.005,835.0010,898.001,151.00779.00838.00295.00328.00
Total Long-Term Assets153,384.00142,959.00160,371.00147,733.00171,379.0029,757.0033,224.006,069.007,956.007,016.0011,849.001,933.001,718.001,875.001,034.001,950.00
Total Assets356,314.00277,079.00378,269.00590,969.00419,268.00181,042.00136,969.0095,936.00116,328.0067,278.0048,995.0011,090.0016,535.0026,575.0026,982.0045,704.00
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment13,816.0015,133.0016,366.0017,639.0017,872.0018,902.0019,571.0020,581.0021,177.0022,007.00
Goodwill0.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.000.00
Long-Term Investments0.000.000.000.000.000.00136,963.00139,790.00120,556.00116,856.00
Other Long-Term Assets100,085.00115,789.00122,614.00125,320.00130,542.00134,482.000.000.000.000.00
Total Long-Term Assets113,901.00130,922.00138,980.00142,959.00148,414.00153,384.00156,534.00160,371.00141,733.00138,863.00
Total Assets185,706.00200,569.00235,161.00277,079.00313,335.00356,314.00437,492.00378,269.00493,071.00527,421.00
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable6,502.005,905.007,712.005,989.0013,400.004,199.005,328.006,281.006,691.002,519.006,428.004,915.002,329.002,632.002,002.002,398.00
Short-Term Debt25,007.0026,971.0013,736.0098,691.005,255.003,782.003,504.00889.00490.00198.0073.006,446.005,600.000.005,895.00395.00
Other Current Liabilities27,966.0046,650.0031,868.0032,003.0033,134.0028,755.0046,627.0031,075.0019,616.0013,552.009,752.007,070.003,944.005,716.005,340.005,067.00
Current Liabilities59,475.0079,526.0053,316.00136,683.0051,789.0036,736.0055,459.0037,356.0026,307.0016,071.0016,253.0018,431.0011,873.009,318.0018,985.0015,874.00
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable12,499.008,838.004,413.005,905.007,723.006,502.006,182.007,712.005,866.009,552.00
Short-Term Debt6,175.0023,165.0054,057.0026,971.005,770.0025,007.0024,472.0013,736.00106,451.00104,193.00
Other Current Liabilities62,082.0053,500.0024,752.0046,650.0042,130.0027,966.0028,402.0031,868.0033,631.0028,565.00
Current Liabilities80,756.0085,503.0083,222.0079,526.0055,623.0059,475.0059,056.0053,316.00147,176.00143,538.00
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt403,717.00180,049.00347,848.00243,332.00342,584.0032,552.0035,822.00150,559.0084,117.0079,512.0049,769.0026,263.0014,898.0020,103.0013,551.009,360.00
Capital Leases15,632.0019,437.0023,303.0026,736.0034,381.0032,552.0035,822.002,467.001,300.00522.000.000.000.000.000.000.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Total Liabilities480,912.00459,688.00403,252.00505,285.00395,488.00301,794.00245,990.00-4,220.00119,142.00104,725.0075,229.0053,744.0034,919.00241,152.0032,536.0025,234.00
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt97,954.00161,168.00360,991.00180,049.00203,701.00419,349.00447,676.00347,848.00359,847.00362,877.00
Capital Leases15,018.0016,529.0017,997.0019,437.0020,012.0021,205.0022,096.0018,143.0024,137.0025,108.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.00
Total Liabilities406,184.00429,254.00448,714.00459,688.00467,507.00480,912.00508,820.00403,252.00507,023.00506,911.00
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock579.00580.00611.00721,401.00626.00616.00542.00490.00482.00438.00380.00342.00304.00259.00224.00219.00
Retained Earnings-846,755.00-910,345.00-753,530.00-635,717.00-683,134.00-872,672.00-734,611.00650,125.00-523,368.00-469,887.00-403,142.00-328,046.00-254,373.00-214,577.00-176,133.00-147,587.00
Comprehensive Income0.000.000.000.000.000.000.00-4,245.00-3,283.00-2,732.00-2,432.00-2,228.00-2,091.00-1,789.00-2,479.00-2,083.00
Total Common Equity-124,598.00-182,609.00-24,983.0085,684.0023,780.00-872,672.00-734,611.00650,125.00-2,814.00-37,447.00-26,234.00-42,654.00-18,384.00-214,577.00-5,554.0020,470.00
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock700.00599.00580.00580.00579.00579.00579.00611.00628.00628.00
Retained Earnings-1,000,146.00-969,229.00-943,805.00-910,345.00-878,987.00-846,755.00-790,714.00-753,530.00-744,462.00-706,712.00
Comprehensive Income0.000.000.000.000.000.000.000.000.000.00
Total Common Equity-220,478.00-228,685.00-213,553.00-182,609.00-154,172.00-124,598.00-71,328.00-24,983.00-13,952.0020,510.00
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt444,356.00207,020.00361,584.00342,023.00347,839.0032,552.0035,822.00151,448.0084,607.0079,710.0049,842.0032,709.0020,498.0020,103.0019,446.009,755.00
Book Value-124,598.00-182,609.00-24,983.0085,684.0023,780.00-120,752.00-109,021.00100,156.00-2,814.00-37,447.00-26,234.00-42,654.00-18,384.00-214,577.00-5,554.0020,470.00
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.000.000.000.000.000.000.000.000.000.00
Book Value-220,478.00-228,685.00-213,553.00-182,609.00-154,172.00-124,598.00-71,328.00-24,983.00-13,952.0020,510.00
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-186,012.00-3,350.00-156,815.00-117,813.0047,417.00194,235.00-138,061.00-84,486.00-126,757.00-53,481.00-66,745.00-75,096.00-73,673.00-39,796.00-38,444.00-28,546.00-29,251.00
Depreciation & Amortization814.00964.00950.00920.00952.001,386.001,616.001,790.00962.00551.00300.00209.00326.00302.00320.00435.00472.00
Stock-Based Compensation11,389.008,192.0010,493.0011,894.0014,072.0017,630.0014,925.0013,785.0011,713.0012,688.0013,582.009,581.008,918.006,252.004,281.001,927.002,178.00
Change Working Capital39,575.000.0029,742.00242,742.00-118,968.00-14,106.007,584.00-394.004,292.00-172.00-6,213.00-2,263.004,793.003,004.00-1,573.00164.0011,596.00
Change In Accounts Receivable44,074.00-3,178.0040,008.00205,125.00-175,066.00-34,314.0031,344.00-12,367.00-6,172.00-5,107.00-5,520.00-6,125.00-13.000.000.000.000.00
Change In Accounts Payable-4,455.004,582.000.004,682.00-10,665.0014,640.00-19,736.0013,283.0010,544.009,520.00-319.004,195.005,459.00-1,169.00957.001,462.001,462.00
Change In Inventories-7,177.000.000.000.000.0034,314.00-208.00-1,059.00355.00685.00-656.0096.00-568.000.000.000.000.00
Other Non-cash Items-16,548.00-121,900.00-33,173.00-63,017.00-29,956.001,696.0025,861.009,232.0018,982.004,187.001,977.001,045.00738.00502.00354.00-28,194.00174.00
Cash from Operations-155,237.000.000.0074,726.00-86,483.00-109,722.00-100,086.00-60,073.00-103,737.00-36,227.00-51,504.00-65,209.00-58,044.00-29,695.00-34,551.00-25,668.00-14,502.00
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income86,451.00-30,917.00-25,424.00-37,565.00-31,358.00-32,232.00-65,125.00-37,184.00-39,287.00-37,750.00
Depreciation & Amortization-2,001.00240.00200.00289.00301.00237.00208.00204.00205.00197.00
Stock-Based Compensation1,733.001,941.002,065.000.002,426.002,641.000.002,658.002,728.003,235.00
Change Working Capital20,234.0014,049.0018,338.001,896.007,969.005,248.0016,081.00-270.006,564.0017,200.00
Change In Accounts Receivable-4,009.001,250.00-5,882.007,345.0038,306.001,686.0010,482.009,817.009,477.0014,298.00
Change In Accounts Payable-1,753.000.000.00-4,977.000.000.00-1,381.00-4,997.00941.00982.00
Change In Inventories0.000.000.000.000.000.000.000.00-7,177.000.00
Other Non-cash Items-146,259.00-3,786.00-17,117.00-461.00-8,318.00-7,952.004,370.00-7,188.00-3,601.00-8,249.00
Cash from Operations0.000.000.000.000.000.000.000.00-34,825.00-32,647.00
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-289.00-65.00-165.00-426.00-113.00-277.00-283.00-334.00-567.00-350.00-126.00-240.00-28.00-204.00-642.00-1,241.00-8,438.00
Acquisitions-173.560.000.000.000.00125,993.000.000.000.000.00126.00240.0028.000.000.0033.000.00
Investments-981,915.00-185,312.00-987,385.00-1,018,602.00-429,045.00-32,006.00-133,194.00-58,217.00-68,782.00-65,326.00-73,966.00-91,766.00-58,849.00-47,182.00-49,547.00-9,000.00-57,765.00
Sales of Investment1,166,839.00109,900.001,069,767.001,046,482.00301,594.00100,000.0066,446.0055,150.0094,500.0028,078.0057,757.0071,400.0065,034.0055,295.0049,282.0027,150.0078,496.00
Other Investing Activities127,781.200.000.000.000.000.000.000.000.000.00-126.00-240.00-28.000.000.00-33.007,631.00
Cash from Investing184,635.000.000.0027,454.00-127,564.00193,710.00-67,031.00-3,401.0025,151.00-37,598.00-16,335.00-20,606.006,157.007,909.00-907.0016,909.0019,924.00
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure0.00-11.00-13.00-41.00-26.00-1.00-80.00-58.00-118.00-33.00
Acquisitions0.000.000.000.000.000.000.000.00-116.36-57.20
Investments-166,854.00-17,350.00-390.00-718.00-65,566.00-295,768.00-138,497.00-487,554.00-179,007.00-176,857.00
Sales of Investment38,400.0010,500.0021,700.0039,300.00100,546.00331,807.00211,727.00425,687.00295,368.00234,057.00
Other Investing Activities0.000.000.000.000.000.000.000.00116,361.0057.20
Cash from Investing0.000.000.000.000.000.000.000.00116,243.0057,167.00
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-237,964.000.000.00-100,428.00-1,167.00-1,823.00-126,833.00-1,139.00-144,930.00-431.00-75,837.00-7,438.00-1,464.000.00-6,194.00-1,051.00-13,005.00
Debt Issued340,966.00207,020.00-154,564.00119,989.00-4,649.00317,110.00123,563.00-114,487.00211,771.005,328.00105,705.0024,571.0013,675.00395.006,851.0010,742.0022,760.00
Issuance of Common Stock-62.000.000.00150.00415.000.0093,675.0054,238.000.0063,657.0038,039.0079,076.0037,754.0020,988.0032,306.00595.00299.00
Repurchase of Common Stock-16,505.000.00-11,851.00-4,654.000.000.000.000.000.000.000.000.000.000.000.003,146.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-3,146.000.00
Other Financing Activities4,682.000.000.00-1,152.00125,000.008,142.00207,692.007,598.00225,983.0011,769.00106,496.0015,188.0014,567.00662.006,861.009,942.009,742.00
Cash from Financing-33,881.000.000.00-106,084.00124,248.006,319.00174,534.0060,697.0081,053.0074,995.0068,698.0086,826.0050,857.0021,650.0032,973.009,486.00-2,964.00
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.000.00-536.00
Debt Issued104,129.00-80,204.00-230,715.00208,028.00-2,451.00-234,885.00-27,792.00110,564.0020,710.0056.00
Issuance of Common Stock0.000.000.000.000.000.000.000.00-150.0053.00
Repurchase of Common Stock0.000.000.000.000.000.000.00-11,851.00-4,654.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.00-104,953.0053.00
Cash from Financing0.000.000.000.000.000.000.000.00-104,953.00-483.00
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-4,483.006,260.00-3,705.00-3,904.00-89,799.0090,307.007,417.00-2,777.002,467.001,170.00859.001,011.00-1,030.00-136.00-2,485.00727.002,458.00
Closing Cash Balance2,120.009,660.003,400.007,105.0011,009.00100,808.0010,501.003,084.005,861.003,394.002,224.001,365.00354.001,384.001,520.004,005.003,278.00
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash7,265.00491.00-2,357.00861.001,879.00-599.00289.00-5,274.00-23,535.0024,037.00
Closing Cash Balance9,660.002,395.001,904.004,261.003,400.001,521.002,120.001,831.007,105.0030,640.00
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-155,526.00-116,159.00-148,968.0074,300.00-86,596.00-109,999.00-100,369.00-60,407.00-104,304.00-36,577.00-51,630.00-65,449.00-58,072.00-29,899.00-35,193.00-26,909.00-22,940.00
Real Free Cash Flow-166,915.00-124,351.00-159,461.0062,406.00-100,668.00-127,629.00-115,294.00-74,192.00-116,017.00-49,265.00-65,212.00-75,030.00-66,990.00-36,151.00-39,474.00-28,836.00-25,118.00
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-39,842.00-18,484.00-21,951.00-35,882.00-29,006.00-32,059.00-46,065.00-41,838.00-34,943.00-32,680.00
Real Free Cash Flow-41,575.00-20,425.00-24,016.00-35,882.00-31,432.00-34,700.00-46,065.00-44,496.00-37,671.00-35,915.00
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-6.3-6.1-1.4
P/S0-6784.79.4
P/B-3.4-10.75.2
P/FCF-6.8-6.8-1.5
Market cap$0.4$0.6
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets56.1 %103.7 %0 %
Debt to Income-3108.3 %-47.6 %0 %
Debt to Free cash flow-85.4 %-113 %0 %
Interest expense percentage-6.8 %-12.9 %44.7 %
Current ratio0.9 2.8 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE1.5 %117.7 %0 %
ROA-1.8 %-101.7 %0 %
CapEx to Revenue0 %-418.6 %0 %
RaD to Revenue0 %-193933.7 %0 %
ROEM0.0 249796.5

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin0 %80 %68.7 %
Operating margin0 %183436.2 %35.5 %
Net margin0 %-316229.4 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding66.3 mil 44.3 mil
Employee count0.2 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader